AR021509A1 - Derivados de benzofurano, su preparacion y uso - Google Patents
Derivados de benzofurano, su preparacion y usoInfo
- Publication number
- AR021509A1 AR021509A1 ARP990106110A ARP990106110A AR021509A1 AR 021509 A1 AR021509 A1 AR 021509A1 AR P990106110 A ARP990106110 A AR P990106110A AR P990106110 A ARP990106110 A AR P990106110A AR 021509 A1 AR021509 A1 AR 021509A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- indolyl
- trifluoromethyl
- alkenyl
- Prior art date
Links
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical class C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 title 1
- -1 hydroxy, formyl Chemical group 0.000 abstract 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 2
- 125000004754 (C2-C12) dialkylamino group Chemical group 0.000 abstract 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 2
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- WTVXIBRMWGUIMI-UHFFFAOYSA-N trifluoro($l^{1}-oxidanylsulfonyl)methane Chemical group [O]S(=O)(=O)C(F)(F)F WTVXIBRMWGUIMI-UHFFFAOYSA-N 0.000 abstract 2
- 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 abstract 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 abstract 1
- 125000006621 (C3-C8) cycloalkyl-(C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000006598 aminocarbonylamino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000001907 coumarones Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11136098P | 1998-12-08 | 1998-12-08 | |
| DKPA199801631 | 1998-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021509A1 true AR021509A1 (es) | 2002-07-24 |
Family
ID=43768792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990106110A AR021509A1 (es) | 1998-12-08 | 1999-12-01 | Derivados de benzofurano, su preparacion y uso |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1137644B9 (enExample) |
| JP (1) | JP2002531556A (enExample) |
| AR (1) | AR021509A1 (enExample) |
| AT (1) | ATE249451T1 (enExample) |
| AU (1) | AU759248B2 (enExample) |
| CA (1) | CA2353618A1 (enExample) |
| CZ (1) | CZ20012041A3 (enExample) |
| DE (1) | DE69911243T2 (enExample) |
| DK (1) | DK1137644T3 (enExample) |
| ES (1) | ES2204175T3 (enExample) |
| HU (1) | HUP0104510A3 (enExample) |
| IL (1) | IL143082A (enExample) |
| ME (1) | MEP38508A (enExample) |
| PT (1) | PT1137644E (enExample) |
| RS (1) | RS50065B (enExample) |
| SE (1) | SE1137644T5 (enExample) |
| SI (1) | SI1137644T1 (enExample) |
| WO (1) | WO2000034263A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| EA008373B1 (ru) * | 2000-07-07 | 2007-04-27 | Х. Лундбекк А/С | Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом |
| EA008372B1 (ru) * | 2000-07-07 | 2007-04-27 | Х.Лундбекк А/С | Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой |
| HUP0302778A3 (en) * | 2000-07-21 | 2005-02-28 | Lundbeck & Co As H | Novel compounds and their use as glycine transport inhibitors |
| AU2001288605A1 (en) * | 2000-09-06 | 2002-03-22 | Chugai Seiyaku Kabushiki Kaisha | A traceless solid-phase synthesis of 2-imidazolones |
| US7235569B2 (en) | 2003-05-02 | 2007-06-26 | Wyeth | Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| JP6064062B2 (ja) | 2013-03-15 | 2017-01-18 | ファイザー・インク | Ａｍｐｋを活性化させるインダゾール化合物 |
| KR20240017363A (ko) * | 2021-06-02 | 2024-02-07 | 세인트 조셉스 유니버시티 | 플루오린화 트립타민 화합물, 이의 유사체 및 이를 사용하는 방법 |
| WO2025104490A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143703A (enExample) * | 1965-03-18 | |||
| GB1173312A (en) * | 1966-03-17 | 1969-12-10 | Kefalas As | Heterocyclic Compounds |
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| DE69419778T2 (de) * | 1993-12-28 | 1999-12-09 | Pharmacia & Upjohn Co., Kalamazoo | Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen |
| ZA954689B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
-
1999
- 1999-12-01 AR ARP990106110A patent/AR021509A1/es unknown
- 1999-12-03 ES ES99957263T patent/ES2204175T3/es not_active Expired - Lifetime
- 1999-12-03 SE SE99957263T patent/SE1137644T5/xx unknown
- 1999-12-03 SI SI9930412T patent/SI1137644T1/xx unknown
- 1999-12-03 DE DE69911243T patent/DE69911243T2/de not_active Expired - Fee Related
- 1999-12-03 WO PCT/DK1999/000676 patent/WO2000034263A1/en not_active Ceased
- 1999-12-03 PT PT99957263T patent/PT1137644E/pt unknown
- 1999-12-03 CA CA002353618A patent/CA2353618A1/en not_active Abandoned
- 1999-12-03 RS YUP-384/01A patent/RS50065B/sr unknown
- 1999-12-03 HU HU0104510A patent/HUP0104510A3/hu unknown
- 1999-12-03 ME MEP-385/08A patent/MEP38508A/xx unknown
- 1999-12-03 CZ CZ20012041A patent/CZ20012041A3/cs unknown
- 1999-12-03 AT AT99957263T patent/ATE249451T1/de not_active IP Right Cessation
- 1999-12-03 DK DK99957263T patent/DK1137644T3/da active
- 1999-12-03 IL IL14308299A patent/IL143082A/en not_active IP Right Cessation
- 1999-12-03 EP EP99957263A patent/EP1137644B9/en not_active Expired - Lifetime
- 1999-12-03 AU AU15036/00A patent/AU759248B2/en not_active Ceased
- 1999-12-03 JP JP2000586710A patent/JP2002531556A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1137644B1 (en) | 2003-09-10 |
| DK1137644T3 (da) | 2003-12-08 |
| IL143082A0 (en) | 2002-04-21 |
| WO2000034263A1 (en) | 2000-06-15 |
| DE69911243D1 (de) | 2003-10-16 |
| ATE249451T1 (de) | 2003-09-15 |
| AU1503600A (en) | 2000-06-26 |
| PT1137644E (pt) | 2004-01-30 |
| JP2002531556A (ja) | 2002-09-24 |
| CZ20012041A3 (cs) | 2001-10-17 |
| HUP0104510A2 (hu) | 2002-04-29 |
| SE1137644T5 (enExample) | 2004-05-11 |
| MEP38508A (en) | 2011-02-10 |
| EP1137644B9 (en) | 2004-03-17 |
| RS50065B (sr) | 2009-01-22 |
| YU38401A (sh) | 2005-06-10 |
| EP1137644A1 (en) | 2001-10-04 |
| CA2353618A1 (en) | 2000-06-15 |
| IL143082A (en) | 2004-06-20 |
| SI1137644T1 (en) | 2003-12-31 |
| ES2204175T3 (es) | 2004-04-16 |
| SE1137644T3 (enExample) | 2003-12-02 |
| HUP0104510A3 (en) | 2003-01-28 |
| AU759248B2 (en) | 2003-04-10 |
| DE69911243T2 (de) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2213007T3 (es) | Derivados de 4,5-diaril-3(2h)-furanona como inhibidores de la ciclooxigenasa-2. | |
| AR020851A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos | |
| UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| DK0628311T3 (da) | Xanthinderivater som antidepressive midler | |
| DE60204674D1 (de) | Retinoid x rezeptormodulatoren | |
| HRP20000854B1 (en) | Therapeutic biaryl derivatives | |
| DE69710319D1 (de) | Para-substituierte phenylpropansäure derivate als integrin-antagonisten | |
| ES2195933T3 (es) | Nuevos derivados de flavonas, xantonas y cumarinas. | |
| EP0994100A4 (en) | 3-anilino-2-CYCLOALKENONDERIVATE | |
| FI952709A0 (fi) | 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina | |
| MX9206169A (es) | Derivados de quinoleina, su preparacion y su aplicacion en terapeutica. | |
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| DE69125811D1 (de) | Verfahren zur Herstellung substituierter Benzofuranderivate | |
| EA200101181A1 (ru) | Циклотиокарбаматные производные в качестве модуляторов рецептора прогестерона | |
| DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
| AR039192A1 (es) | Derivados de diazabicicloalcano con actividad antagonista de nk1 | |
| SG164268A1 (en) | Quinolin-4-yl derivatives i | |
| DE69911176D1 (de) | Spiropiperidin-derivate | |
| FR2672892B1 (fr) | Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique. | |
| NO164593C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbamat- eller urea-derivater. | |
| ES2132245T3 (es) | Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht. | |
| CO4440625A1 (es) | Derivados de acido 2-amino-2-(2-carboxicilopropil)acetico y procedimiento para su preparacion | |
| CO4950554A1 (es) | Derivados de 1,3-dihidro o 3,4-dihidroisoquinolin-benzamida | |
| BRPI0414597A (pt) | derivados de benzofurano do tipo carbamoìla | |
| ES517042A0 (es) | Procedimiento para la preparacion de una aroilimidazolidin-2-ona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |